ISSN (Print):
ISSN (Online):
Download PDF Flyer

Current Drug Targets

Impact Factor: 3

Indexed in: Scopus, SCI Expanded, MEDLINE/PubMed... View all

Volume 25 , Issues 15, 2024

Back Journal Home

Institutional Members

Editorial Board

cdt Editor-in-Chief Castellino Francis J. Dean Emeritus, College of Science, Kleiderer-Pezold Professor of Biochemistry Director, W.M. Keck Center for Transgene Research 230 Raclin-Carmichael Hall, University of Notre Dame Notre Dame, IN 46556 USA

Dr. Francis J. Castellino has been serving as Adjunct Professor of Biochemistry & Molecular Biology, at Indiana University School of Medicine since 2006. Besides, he is also the director of WM Keck Center for Transgene Research, University of Notre Dame since 1996, and a Professor of Biochemistry, at the University of Notre Dame. He did a Ph.D. in Biochemistry, from the University of Iowa. He received a number of awards such as the 2020 ISTH Esteemed Career Award, the University of Iowa Carver College of Medicine Distinguished Alumnus Award, etc. His research focus is on the structure, function, and activation of proteins that participate in blood coagulation and blood clot dissolution and structure-function relationships of small gamma-carboxyglutamic acid (Gla)-containing peptides from marine cone snails that target the brain NMDA receptor. He has been involved in a number of scientific publications. Scopus RsearcherId
Regional Editors Europe cdt_ebm_danese_001 Danese Silvio Istituto Clinico Humanitas-IRCCS Milan Italy

Silvio Danese is a Gastroenterologist at Humanitas Research Hospital in Milan, and Professor in gastroenterology at Humanitas University, Italy. He is Head of the Inflammatory Bowel Disease Center in the Division of Gastroenterology. He trained in Gastroenterology at Policlinico Gemelli, Rome and graduated as a PhD, working from 2001 to 2004 in Dr. Claudio Fiocchi’s laboratory at the Case Western Reserve University, Cleveland, Ohio, USA. His area of interest is the investigation of the fundamental mechanisms underlying IBD pathogenesis, while his daily clinical activity is related to IBD service. He is a member of many organisations related to the IBD field, including the European Crohn´s and Colitis Organization. Orcid Scopus RsearcherId
cdt_ebm_filosto-ah_001 Filosto Massimilano Center for Neuromuscular Diseases University of Brescia Brescia Italy

Dr. Massimilano Filosto has obtained his PhD in Neurosciences at University of Verona after a postdoctoral research fellowship at the Department of Neurology, Columbia University, New York, USA. He is a member of the Treat- NMD Neuromuscular Network. His main interests is in the field of Neuroscience are muscle, nerve and motor neuron diseases. His work focuses on metabolic myopathies,genotype/phenotyperelations,epigenetic and pathological findings in mitochondrial diseases and muscle glycogenoses. He is full Individual Member of the European Academy of Neurology and participates to expert panels in neuromuscular diseases, peripheral neuropathies and motor neuron diseases. Orcid Scopus RsearcherId
North America Ploplis Victoria A. University of Notre Dame Notre Dame, IN USA Scopus RsearcherId
Frontiers Section Editors cdt_ebm_azevedo_001 De Azevedo Walter F. Jr Pontifical Catholic University of Rio Grande do Sul-Brazil Porto Alegre-RS Brazil

Dr. Azevedo is professor of Biophysics, Bioinformatics, Computational Systems Biology, Machine Learning and Drug Design at Pontifical Catholic University of Rio Grande do Sul-Brazil ( He is Regional Editor for Current Drug Target, member of the Editorial Board for Current Bioinformatics and PeerJ, and Guest Editor for Current Medicinal Chemistry. His research is focused on protein-ligand interactions. He works on the development of computational models to study protein-ligand interactions and their applications to drug design. He has over 170 publications with h-index of 35. Bioinformatics and Biophysics Orcid Scopus RsearcherId
cdt_ebm_urano_001 Urano Tetsumei Department of Physiology Hamamatsu University School of Medicine Hamamatsu Japan

Dr. Urano obtained doctorates (M.D., Ph.D.) from the Hamamatsu University School of Medicine, Hamamatsu, Japan. Dr. Urano finished post doctoral fellow in the University of Notre Dame, USA. Currently Dr. Urano is a vice president and the professor of the department of medical physiology in the Hamamatsu University School of Medicine. He has studied in the field of coagulation and fibrinolysis as well as vascular biology, and published more than 180 scientific publications. Dr. Urano is currently the regional editor of this journal (Current Drug Targets), published by Bentham Science Publishers. Medical Physiology Orcid Scopus RsearcherId
Section Editors cdt_ebm_Cicione-sh_001 Cicione Antonio Francesco Sant’Andrea Hospital – Sapienza University of Rome Rome Italy

Dr. Antonio Ciccone is a urologist at Sant’Andrea Hospital - “La Sapienza'' University in Rome where he received his training. His postdoctoral research was carried out at “Magna Graecia”University of Catanzaro and focused on minimal invasive urological surgery. Furthermore, He was clinical as well as a research fellow at Universidade do Minho in Braga-Portugal. His research area is focused on Lower Urinary Tract Symptom mainly to improve the treatment and management. Lower Urinary Tract Symptoms – LUTS, management and therapy Orcid Scopus RsearcherId
cdt_ebm_Dang-sa_001 New drug therapy for eye diseases Dang Yalong Department of Ophthalmology Sanmenxia Eye Hospital (Eye Institute) Sanmenxia, Henan China Orcid Scopus RsearcherId cdt_ebm_Dong-sa_001 Cancer Bioinformatics Dong Peixin Department of Obstetrics and Gynecology Hokkaido University School of Medicine Sapporo Japan

Dr. Dong Peixin is an Assistant Professor of Obstetrics and Gynecology, Hokkaido University, Japan. He received his Ph.D. degree from the Hokkaido University in 2008. He is currently working on the roles of genetic and epigenetic mechanisms (especially non-coding RNA networks) underlying cancer stem cells, EMT, chemoresistance and cancer metastasis. He has published more than 60 papers in international journals, and his research works have been cited for over 2974 times, and his current h-index is 32. He has been serving as Associate Editor and Editorial Board member of several international journals.

Orcid Scopus RsearcherId
Section Editor (Special Issues) cdt_ebm_Ghidini-se_001 Ghidini Michele Division of Medical Oncology Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy Orcid Scopus RsearcherId cdt_ebm_Kontos-sa_001 Kontos Christos K. Department of Biochemistry and Molecular Biology Faculty of Biology National and Kapodistrian University of Athens Athens Greece Orcid Scopus RsearcherId cdt_ebm_Shuai-sa_001 Wang Shuai School of Pharmaceutical Sciences Guangzhou University of Chinese Medicine Guangzhou China Orcid Scopus RsearcherId Assistant Editor DeFord M.E. Department of Chemistry and Biochemistry University of Notre Dame Notre Dame, IN USA Scopus RsearcherId Editorial Board Members cdt_ebm_cavaliere_001 Cavaliere Franco Institute of Intensive Care Medicine and Anesthesiology Catholic University of the Sacred Heart Rome Italy

Prof Franco Cavaliere is Associate professor of Anesthesia and Intensive Care at the Catholic University of the Sacred Heart in Rome (Italy) and serves as the Head of Cardiac Anaesthesia and Cardiac Surgical Intensive Care at Policlinico Agostino Gemelli in Rome. He has published more than 200 scientific publications and is a member of the Editorial Board of Current Drug Targets from 2002. Scopus RsearcherId
cdt_ebm_Cruz-Topete-sh_001 Cruz-Topete Diana Department of Physiology LSU Health Sciences Center-Shreveport Shreveport, LA USA Scopus RsearcherId cdt_ebm_dahl_001 Dahl Karen D.C. Kabara Cancer Research Institute Gundersen Medical Foundation La Crosse, WI USA

Dr. Cowden Dahl earned her BS in cell and molecular biology at Texas Tech University. Following undergraduate work. Dr. Cowden Dahl completed a PhD in cell and molecular biology at the University of Pennsylvania. Her dissertation work was conducted with Dr. Celeste Simon on hypoxia signaling in development and cancer. Dr. Cowden Dahl then conducted a postdoctoral fellowship with Dr. Laurie Hudson at the University of New Mexico. Her studies focused on ovarian cancer metastasis. In 2010 Dr. Cowden Dahl joined the Indiana University School of Medicine-South Bend where she continues to investigate mechanisms of ovarian cancer progression. Scopus RsearcherId
Epifano Francesco Department of Pharmacy Università "G. D'Annunzio" Chieti Scalo Italy Orcid Scopus RsearcherId cdt_ebm_Feldman_001 Feldman Eva L. Department of Neurology University of Michigan Ann Arbor, MI USA

Dr. Feldman is a world renowned researcher, the Russell N. DeJong Professor of Neurology at the University of Michigan Medical School, and director of the A. Alfred Taubman Medical Research Institute. She was elected to the National Academy of Medicine in 2014, and was honored as National Physician of the Year for Clinical Excellence in 2016. In addition to her practice, she runs a 30-person research lab which focuses on understanding and treating neuromuscular and neurodegenerative diseases, with an emphasis on ALS and neuropathy, and she is the principle investigator of numerous NIH and foundation grants. Orcid Scopus RsearcherId
Hasselbalch Hans C. Department of Oncology-Hematology University of Copenhagen Roskilde Denmark Orcid Scopus RsearcherId cdt_ebm_iwaki-t_001 Iwaki Takayuki Department of Pharmacology Hamamatsu University School of Medicine Shizuoka Japan

Dr Takayuki Iwaki is currently an Associate Professor at the Hamamatsu University School of Medicine, Department of Pharmacology, Hamamatsu, Japan. He received a PhD in Physiology from the Hamamatsu University School of Medicine in 2001 and also did his M.D. in Obstetrics and Gynecology from the same university in 1996. He has published several articles in distinguished journals and has presented in various conferences as well. Scopus RsearcherId
cdt_ebm_lee_001 Lee Shaun Department of Biological Sciences University of Notre Dame Notre Dame, IN USA

Dr. Lee obtained a B.A. from the University of California Berkeley, and a doctorate (Ph.D.) in Molecular Microbiology and Immunology from Oregon Health Sciences University. Dr. Lee completed postdoctoral training at University of California San Diego, and is currently the Monahan Family Associate Professor in the Department of Biological Sciences at the University of Notre Dame. Dr. Lee’s lab focuses on host-pathogen dynamics of bacterial infections. Scopus RsearcherId
cdt_ebm_magnani_001 Magnani Mauro Department of Biomolecular Sciences University of Urbino Urbino Italy

Dr. Magnani is a co-founder of two start-up companies Diatheva SrL ( and EryDel SpA ( He is a member of different academies and scientific boards. He served as evaluator for different Programmes of the E.U.; included, The International Science Foundation (U.S.A.); Czech Academy of Sciences; The Executive Agency for Higher Education, Research, Development and Innovation Funding of Romania; Deutsche Forschungsgemeinschaft (DFG; German Research Foundation), Dutch Cancer Society; Swiss National Science Foundation; Innovation and Technology Commission, The Government of Hong Kong, and EU Eureka projects. He is a reviewer for more than 50 journals and editorial board member in four journals. He has more than 500 papers published in international refereed scientific journals (for a complete list see PubMed) and an H index of 54. He has interests in drug delivery systems and biologics with 14 patent families in the field. Orcid Scopus RsearcherId
cdt_ebm_Kaur_001 Mandeep Kaur School of Molecular and Cell Biology University of the Witwatersrand Johannesburg South Africa

Prof Mandeep Kaur is a Full Professor at the School of Molecular and Cell Biology, University of the Witwatersrand, Johannesburg, South Africa. The core of her research is to understand the ‘biology underlying the complex diseases’ like cancer using bioinformatics and cell biology based approaches. Her research interests include delineating the role of cholesterol in cancer, devising new cancer therapeutics, advancing understanding of cancer drug resistance mechanisms and biomarker identification. Prof Kaur is an Associate Editor for Frontier in Genetics, and an editorial board member of BMC Cancer and IUBMB Life.

Orcid Scopus RsearcherId
Parmer Robert J. Department of Medicine University of California San Diego, CA USA Scopus RsearcherId cdt_ebm_ranson_001 Ranson Marie School of Chemistry and Molecular Bioscience University of Wollongong Wollongong Australia

Professor Marie Ranson (PhD, University of Sydney, 1990) is a tenured Teaching and Research Academic at the University of Wollongong, Australia. She has made major contributions to the field of the urokinase plasminogen activation system in cancer invasion and metastasis and leads several cancer drug projects related, but not limited, to this field. Prof Ranson has published over 78 peer-reviewed journal articles, attracted several competitive grants totalling over $10,000,000, and has been granted patents in her drug development portfolio. She led the preclinical development of chemotherapy Deflexifol, licenced to FivePhusion Pty Ltd, which is completing Phase 1 clinical trials. Prof Ranson is also a PI of the Cancer Institute NSW-funded Translational Cancer Research Centre to build research capacity in targeted therapies and is a member of a number of professional societies. Orcid Scopus RsearcherId
cdt_ebm_ak-Saha-sh_001 Saha Asish K. Department of Research & Development Zone Labs Inc Peabody, MA USA

Dr. Asish Saha is presently serving as a Director of Research and Development at Zone Labs, Inc and working in the dietary supplements, health wellness, and fitness industry. He holds a Ph.D. in Biochemistry from Calcutta University, India. His research interests include how disorders of fuel metabolism cause disease. He has extensive experience with preclinical testing of metabolic pathways targets using in vitro and in vivo models. He was an investigator in a multi-investigator project which provided the first evidence that AMP-activated protein kinase activity is abnormally low in the majority of patients and it improves after bariatric surgery. He demonstrated success as a leading investigator and collaborator of multiple projects with different Biotech companies (Nimbus Therapeutics, L’Oréal, and Pfizer) and with Nimbus the discovery and development of a new class of Acetyl Co-A carboxylase inhibitors for the treatment of NASH and other disorders. He has co-authored 95 publications in international journals. Scopus RsearcherId
Scheel Molly D. Department of Medical and Molecular Genetics Indiana University School of Medicine South Bend, IN USA Scopus RsearcherId cdt_ebm_smyth_001 Smyth S. Department of Medicine University of Kentucky Lexington, KY USA

Susan S. Smyth, is the Jeff Gill Professor of Cardiology, Chief of the Division of Cardiovascular Medicine, Director of the Linda and Jack Gill Heart Institute, and Director of the MD/PhD Program at the University of Kentucky. She also has a part-time appointment as a cardiologist and funded investigator at the Lexington VA Medical Center. Smyth received her A.B. in Biology, summa cum laude, from Mount Holyoke College (South Hadley, Massachusetts), and graduated from the MD/PhD Program at the University of North Carolina (Chapel Hill). After completing training in Internal Medicine, she performed cardiology subspecialty fellowship training at the Mount Sinai School of Medicine (New York, New York) and at the University of North Carolina. She is a member of the American Society of Clinical Investigation, the Association of University Cardiologists, a fellow of the American College of Cardiology, and a fellow of the American Heart Association. Scopus RsearcherId
cdt_ebm_sun_001 Sun Hongmin Department of Medicine University of Missouri Columbia, MO USA

Dr. Sun obtained a doctorate (Ph.D.) in Biomedical Science from University of Texas Health Science Center at Houston. She is an Associate Professor of Medicine at University of Missouri School of Medicine. She is a geneticist who is interested in host/pathogen interaction and development of novel antimicrobials. She has a wide range of interest in cardiovascular and infectious disease research. Her main research focus is to understand and explore the roles of hemostatic system in host/pathogen interaction for development of novel antimicrobials. Scopus RsearcherId
Yepes Manuel S. Department of Neurology Emory University School of Medicine Atlanta, GA USA Scopus RsearcherId Yi Dong Kee Department of Chemistry Myongji University Yongin South Korea Orcid Scopus RsearcherId cdt_ebm_li_001 Zhang Li Department of Physiology University of Maryland School of Medicine Baltimore, MD USA

Dr. Zhang obtained his Ph.D. in Molecular Biology from the University of Notre Dame, Indiana. He currently is an Associate Professor at the University of Maryland, School of Medicine. Dr. Zhang has more than 25 years of experience in blood coagulation, immunology, and stem cell biology. Projects in Dr. Zhang’s laboratory range from structure-function analysis, leukocyte trafficking, signal transduction to animal models of cardiovascular and inflammatory diseases, such as atherosclerosis, sepsis, rheumatoid arthritis, and ischemic stroke. Dr. Zhang has authored more than 60 manuscripts, 2 patents, and served on various Study Sections at NIH, DOD and AHA. Scopus RsearcherId
Associate Editorial Board Member cdt_ebm_mandal-cc_001 Mandal Chandi C. Department of Biochemistry Central University of Rajasthan Ajmer India

Dr. Chandi C. Mandal is a Professor at the Department of Biochemistry, Central University of Rajasthan, India [2013-to present]. He completed his postdoctoral training from the University of Texas Health Science Center at San Antonio, Texas, USA [2006-2012]. He has obtained his Ph.D. from the Indian Institute of Technology at Kharagpur, India [2000-2005], and M.Sc. (Biochemistry) from Calcutta University, India. Dr. Mandal’s academic endeavor is not only reflected in the publication, but his research work has also been highlighted multiple times in Newspapers and reported in Television channels. His research interest is aimed at understanding the cellular signal transduction mechanisms involved in cancer, metastasis and bone remodeling. Prof. Mandal is an Editorial Board Member of various journals such as Frontiers in Endocrinology, BMC cancer, PLOS ONE and Journal of Biochemical and Molecular Toxicology. Prof. Mandal has edited the thematic issue on “cancer and bone metastasis”. Scopus RsearcherId
cdt_ebm_Cheriyan-cc_001 Cheriyan John Department of Ophthalmology and Visual Sciences University of Utah Salt Lake City, UT USA Orcid Scopus RsearcherId
Executive Guest Editor(s) cdt_ebm_campa-c-ah_001 Campa Claudio University of Ferrara Ferrara Italy

Dr. Claudio Campa has been affiliated with the University of Ferrara, Italy, where he received his PhD in Pharmacology and Molecular Oncology, in 2008. He has authored many scientific papers in various journals including peer-reviewed journals that are indexed in PubMed, journals cited in current contents or index medicus and book chapters. Being an editorial board member, he is actively involved in Case Reports of Ophthalmological Medicine (Hindawi Publishing Corporation) (since 2014) and World Journal of Ophthalmology (Baishideng Publishing) (since 2012). As a co-investigator and sub-investigator, he has served many years in research specifically in clinical investigations. Scopus RsearcherId
cdt_ebm_fattore-a-ah_001 Del Fattore Andrea Bambino Gesù Children’s Hospital Rome Italy

Dr. Andrea Del Fattore is currently serving as a head of the Bone Physiopathology Group, Multifactorial Disease and Complex Phenotype Research Area, in Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy. He received a PhD degree in Biotechnology from the Department of Experimental Medicine, University of L’Aquila, Italy, in 2009. Later, in 2017 he completed his post-graduation with Specialization in Clinical Pathology and Clinical Biochemistry Tor Vergata, University of Rome, Italy. He has been actively involved in the editorial board of several international journals, various international committees and acted as reviewer in many highly reputed journals. Dr. Fattore has published over 40 articles, 3 book chapters and more than 30 abstracts till date. Orcid Scopus RsearcherId
cdt_ebm_xy-Hua-sh_001 Hua Xu Y. Faculty of Chinese Medicine Macau University of Science and Technology Macau China

Dr. Xu is the Associate Professor at Faculty of Chinese Medicine, State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology. He specializes in researches on pharmacology, cardiovascular and metabolic diseases, and discovery and evaluation of effective components from Chinese Medicines. His research interests mainly include: (1) study of Chinese Medicines on diabetes; (2) effects and mechanism of natural products on cardio-cerebrovascular disease; (3) development and application of alive cell immobilized chromatography on the R&D of Chinese Medicines. He has been awarded prizes including the Second Prize of Science and Technology Invention Award Category of the 2016 Macau Science and Technology Award (the second awardee), and Third Prize of 2011 Science and Technology Award of Jiangsu Province (the seventh awardee), etc. for academic performance. Orcid Scopus RsearcherId
cdt_ebm_johnson-jj-ah_001 Johnson Jeremy J. College of Pharmacy Department of Pharmacy Practice University of Illinois at Chicago Chicago, IL USA

Dr. Jeremy J. Johnson received his Ph.D. degree in Comparative and Biomedical Sciences in 2010 and Pharm.D. degree in 2007 from the University of Wisconsin School of Pharmacy. Dr. Johnson is an Associate Professor at the University of Illinois, Chicago. Currently, he is actively engaged in UI-Centre (University of Illinois Collaborative Engagement in Novel Therapeutics Research Enterprise) as a Pre-Clinical Core Leader and Associate Professor. He has an H-index of 18 with nearly 45 publications including 26 peer reviewed, 18 abstracts and 1 book chapter, respectively.

Scopus RsearcherId
cdt_ebm_Khan-sn-sa_001 Khan Shahper N. Interdisciplinary Biotechnology Unit Aligarh Muslim University Aligarh India

Dr. Shahper Nazeer Khan did M.Sc. in Biotechnology from Awadhesh Pratap Singh University, Rewa, Madhya Pradesh, India, in 2003. He further obtained M.Phil. and Ph.D. degrees in Biotechnology from Interdisciplinary Biotechnology Unit, Aligarh Muslim University, India, in 2006 and 2009. Nowadays, he is serving as an Assistant Professor at Interdisciplinary Nanotechnology Centre and Int. Biotechnology Unit, AMU, India. Dr. Khan has won several awards and received many honors as a consequence of his research and contributions in science, both nationally and internationally. He has published more than 40 papers. In addition to this, he’s also involved as an editorial board member in 6 scientific journals. Orcid Scopus RsearcherId
cdt_ebm_b-Mathew-sh_001 Mathew Bijo Department of Pharmaceutical Chemistry Amrita School of Pharmacy Kerala India

Dr. Bijo Mathew is an Associate Professor of Pharmaceutical Chemistry at Amrita School of Pharmacy, Kochi, India. Dr. Bijo Mathew obtained his M.Pharm in Pharmaceutical Chemistry from The Tamilnadu Dr. M.G.R. Medical University, Tamilnadu, India in 2008 and Ph.D. in Pharmaceutical Sciences from Jawaharlal Nehru Technological University, Hyderabad, India, in 2016. Mathew's primary areas of focus are drug discovery of neurodegenerative disorders, cancer, and molecular modelling. Besides, he is also interested in designing enzyme inhibitors, especially monoamine oxidase and acetylcholinesterase inhibitors. He has published 142 papers, (h-index = 29, the number of citations: 2222 in Google scholar; h-index = 27, the number of citations: 1887 in Scopus, as of March 2021). He has 13 years of teaching and research experience, as well as he has authored 1 book, and edited 1 book, and 5 book chapters. Moreover, he has been invited as a speaker in 25 national and international events. Dr. B. Mathew is serving as a chief executive guest editor for many journals and Section Editor of the journal of Coronaviruses by Bentham Science. He has received one patent from the Korean Intellectual Property of Office on protective or therapeutic compositions of neurological disorders containing Furano chalcones as effective agents. Orcid Scopus RsearcherId
cdt_ebm_d-Pal-sh_001 Pal Dilipkumar A Central University Gandhinagar India

Dr Dilipkumar Pal received his B.Pharm, M Pharm, and PhD from Jadavpur University, Kolkata, India. He also obtained his Post Doctorate from “The University of Sydney”, Australia. Currently, he is an Associate Professor at the Institute of Pharmaceutical Sciences, Guru Ghasidas Viswavidyalaya (A Central University), India. He has won several awards due to his contributions in Science both nationally and internationally. He has published more than 100 research papers, 28 book chapters, 12 review articles, and 112 abstract proceedings in both national and international journals. Besides, he is a Reviewer of 27 scientific journals and an Editorial Board Member of 29 scientific journals respectively. Scopus RsearcherId
cdt_ebm_Scotti-sh_001 Scotti Luciana Federal University of Paraíba João Pessoa, PB Brazil

Luciana Scotti received her Ph.D. in Cosmetology and Molecular Modeling at the University of São Paulo, Brazil. She made 3 years of Post-Doctorate in Pharmaceuticals at the Laboratory of Planning and Synthesis of Potentially Active Chemotherapies in Tropical Endemics, Faculty of Pharmaceutical Sciences, USP. She has experience in Pharmacology Biochemistry and Molecular acting mainly in the following areas: natural products, Molecular Modeling, QSAR, and Chemometrics. She is the professor of the Post-Graduate Program of Bioactive Natural and Synthetic Products of the Federal University of Paraíba, Brazil. Orcid Scopus RsearcherId
cdt_ebm_sountoulidis-p-ah_001 Sountoulidis Petros Aristotle University of Thessaloniki Thessaloniki Greece

Dr. Petros Sountoulidis has been affiliated with Aristotle University of Thessaloniki, Greece, from where he passed MBBS, in 1996. Currently, he is serving as an Assistant Professor of Urology, Department of Urology at the same university. He has been involved with great endeavor in FEBU (Fellow of the European Board of Urology) and was awarded in 2005. He has served 8 years as a Consultant Urological Surgeon, Urology Department, General Hospital of Veria, Greek National Health System. As an editorial board member, he was involved in various esteemed journals and he has served as a reviewer for different Journals and provided 112 reviews in total. So far, he has published 5 book chapters. Orcid Scopus RsearcherId
cdt_ebm_trostchansky-a-ah_001 Trostchansky Andres Department of Biochemistry-School of Medicine Universidad de la República Montevideo Uruguay

Dr. Andrés Trostchansky obtained his Ph.D. in Chemistry at the Universidad de la Republica, Uruguay in 2007. Since 2010 he has been an Associate Professor at the Department of Biochemistry at the Facultad de Medicina. He is Co-PI of the Laboratory of Oxidative Lipid Biochemistry and a member of the Centro de Investigaciones Biomédicas (CEINBIO). Dr. Trostchanksy's main research is focused in lipid metabolism, lipidomics studies in health and disease, nitro-fatty acids and their biological roles in arachidonic acid metabolism (COX and LOX) and reactive oxygen species (NOX and PDI). He served as a mentor for Ph.D. students in Uruguay and Brazil. He has authored/co-authored more than 50 manuscripts and book chapters on a variety of subject matters. He is among the editorial board of Frontiers of Experimental Pharmacology and Drug Discovery, Current Drug Target, and also a Section Editor of Current Medicinal Chemistry. Orcid Scopus RsearcherId
cdt_ebm_valente_001 Valente Joana Center for Rapid and Sustainable Product Development Marinha Grande Portugal

Dr. Joana Valente is a post-doctoral researcher at the Centre for Rapid and Sustainable Product Development. She obtained her PhD in Biochemistry in 2018 from the University of Beira Interior, with the thesis entitled: "Affinity purification and delivery of a p53-encoding plasmid DNA for gene-mediated cancer therapy". Her scientific path began in 2009 when she started to work at the Centre for Rapid and Sustainable Product Development after concluding her degree in Biomechanics. During this period, she worked with 3D printing and surface modification to increase the suitability of the scaffolds for cell adhesion. In 2011, she obtained her Master's degree in Engineering Design and Product Development, from Polytechnic Institute of Leiria with the thesis entitled: "Surface modification of alginate scaffolds". Besides, in 2011, she pursued her career in the Health Sciences Research Centre in the bone regeneration field and, in 2013, she began to work with gene therapy and affinity chromatography. She is the author of several scientific papers and her main research interests include: Tissue Engineering, Biofabrication, Additive Manufacturing, Drug delivery systems development, Biomaterials, Gene therapy and Chromatography. Orcid Scopus RsearcherId
cdt_ebm_Zaid-sh_001 Zaid Hilal M.H. Al-Qasemi Educational Research Center Baka Israel

Dr. Hilal Zaid is presently serving as a Head of Al-Qasemi Educational Research Center, Al-Qasemi Academic College, Baka, Israel. He completed his M.Sc. from the department of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israelin 1996. He further obtained PhD from the same university in 2005. He is also a Management Committee member of European Cooperation in Science and Technology (COST) Action N°CA15129, titled "Diagnosis, Monitoring and Prevention of Exposure-Related Noncommunicable Diseases (DiMoPEx)". Scopus RsearcherId
© 2024 Bentham Science Publishers | Privacy Policy